2015 - Page 7 of 57 - Legal Reader

UPDATE: Fitzpatrick’s E-Free Act Would Take Essure Off the Market

Jay W. Belle Isle - October 27, 2015

Rep. Mike Fitzpatrick (R-PA) is planning to introduce the E-Free Act to Congress on November 4, 2015. This bipartisan bill would ban the dangerous Bayer product Essure from the market. Essure has caused thousands of women intense suffering despited continuous assurances from Bayer that the product is safe. While the FDA had a hearing to discuss that issue in September, no Essure victims were allowed to speak. Representatives from the advocacy groups, Essure Problems, are in Washington D.C. this week meeting with Congress to share their stories and lend support to Fitzpatrick’s bill.

If You’ve Been Injured by Essure, You Are Not Alone

Jay W. Belle Isle - October 26, 2015

If you’re facing the struggles and pain of dealing with Essure, Bayer’s “permanent” birth control device, know that you are not alone. Join the Essure Problems Facebook group to find help, support and those who know and understand what you’re going through.

Essure Causes Debilitating Skin Conditions

Jay W. Belle Isle - October 23, 2015

Essure causes debilitating skin conditions. Tamara Pimentel shares her story of the painful, bleeding rashes she suffered for 3.5 years before realizing that the nickel in her Essure implants was the cause. Upon removal of the Essure coils, Tamara’s rash soon cleared.

What Women Need to Know about Essure

Jay W. Belle Isle - October 22, 2015

Marlo Thomas and Erin Brockovich, neither strangers to standing for a good cause, team up to explain what women need to know about Essure. It’s a brief, but enlightening interview.

Essure Placement Rate Failure

Jay W. Belle Isle - October 21, 2015

Essure “permanent” birth control has an unacceptably high rate of placement failure, even when done by those with experience. Yet, the product was approved and this information was buried. Improper placement can result in organ perforation, among other things, and require surgery to remove the device.

Praxbind is the Pradaxa Antidote

Jay W. Belle Isle - October 21, 2015

The FDA granted fast track approval to Boeheringer’s latest drug offering, Praxbind. This new drug is the long-awaited antidote to new gen anticoagulant, Pradaxa. Preliminary clinical trials suggest an 89% efficacy rate within four hours of IV administration. This could be a life-saving tool for medical providers caring for patients on Pradaxa, a drug known for its high risk of uncontrollable and even fatal belleding events.

Surprise! You’re Pregnant! When Essure Doesn’t Work

Jay W. Belle Isle - October 20, 2015

The failure rate of “permanent” birth control implant, Essure, is several times that which is advertised by Bayer, its maker. In fact, it is several times that of tubal ligation, the surgical procedure Essure was meant to replace.

Why Suing Big Pharma Isn’t Changing Anything

Jay W. Belle Isle - October 20, 2015

Despite hundreds of lawsuits and mind-bogglingly huge settlements, Big Pharma doesn’t seem inclined to clean up its act and produce drugs that are actually safe. None of the current activities seem to matter to the industry. Here’s a look at why suing Big Pharma isn’t changing anything.

A Call to Arms: OB/GYN Speaks Out Against Essure

Jay W. Belle Isle - October 19, 2015

Dr. Julio Novoa, OG/GYN, takes a moment to detail Bayer’s untrustworthy “profits over patients” history as well as provide data on the Essure implantable “permanent” birth control device. The video explains the massive campaign of untruth maintained by Bayer regarding the safety and efficacy of the Essure product.

“If I don’t survive…” An Essure Victim Speaks Out

Jay W. Belle Isle - October 16, 2015

Brandi Casey, a former model and Essure victim, bravely speaks out about her experience with this dangerous medical device. She suffers from metal toxicity and a host of other adverse effects caused by Essure. Yet it’s maker, Bayer, and the FDA continue to tout it as a safe product.

Trending